Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into a Material Definitive Agreement. On January 20, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) entered into an ATM Sales Agreement (the “Sales
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 ATM Sales Agreement, by and between NovaBay Pharmaceuticals, Inc. and Virtu Americ